Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis, 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The global large molecule bioanalytical testing services market size is expected to reach USD 3.70 billion by 2030, registering a CAGR of 9.63% from 2025 to 2030. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry.
The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.
It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the COVID trials. They must also resolve assays that are related to COVID and those that are not.
Large Molecule Bioanalytical Testing Services Market Report Highlights
- The clinical phase segment dominated the market in 2024 with the largest revenue share of 66.6%. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth.
- The global market is segmented into pharmacokinetics, Antidrug Antibodies (ADA), and others. The ADA segment accounted for the largest revenue share of the global market in 2024.
- The bioavailability segment held the largest revenue share in 2024. The segment growth can be attributed to the high demand for these services in generic drug manufacturing.
- Oncology accounted for a majority of revenue share in the global market in 2024. The segment is also anticipated to register the fastest CAGR during the forecast period.
- The SMEs segment dominated the global market in 2024. The segment is also anticipated to grow at the fastest CAGR over the forecast timeline, retaining its market dominance.
- North America large molecule bioanalytical testing services market dominated globally in 2024 with a revenue share of more than 48.94%.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
- Competitive Landscape: Explore the market presence of key players worldwide
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions
This report addresses:
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
The leading players in the Large Molecule Bioanalytical Testing Services market include:
- Laboratory Corporation of America Holdings
- IQVIA
- Syneos Health
- SGS SA
- WuXi AppTec
- Intertek Group plc
- Pace Analytical Services LLC
- ICON plc
- Charles River Laboratories
- Thermo Fisher Scientific
Key Attributes
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $2.13 Billion |
| Forecasted Market Value (USD) by 2030 | $3.7 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological Advancements in Analytical Testing
3.2.1.2. Regulatory Control and Increasing Awareness Regarding Bioanalytical Testing
3.2.1.3. Growing R&D Expenditure in the Pharmaceutical and Biopharmaceutical Industries
3.2.1.4. Rising Demand for Outsourcing of Analytical Testing
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance Issues while Outsourcing
3.2.2.2. Data Security Concerns
3.3. R&D Investments & Funding Perspective
3.4. Clinical Trials Volume Analysis, (2023)
3.5. Pricing Model Analysis
3.6. Technology Landscape
3.7. Large Molecule Bioanalytical Testing Services Market Analysis Tools
3.7.1. Porter's Five Forces Analysis
3.7.2. PESTEL Analysis
Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis
4.1. Large Molecule Bioanalytical Testing Services Market, By Phase: Segment Dashboard
4.2. Global Large Molecule Bioanalytical Testing Services Market by Phase: Movement Analysis
4.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million) for the following:
4.4. Preclinical
4.5. Clinical
Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis
5.1. Large Molecule Bioanalytical Testing Services Market, By Type: Segment Dashboard
5.2. Global Large Molecule Bioanalytical Testing Services Market by Type: Movement Analysis
5.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030 (USD Million) for the following:
5.4. Pharmacokinetics
5.5. ADA
5.6. Others
Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis
6.1. Large Molecule Bioanalytical Testing Services Market, By Test: Segment Dashboard
6.2. Global Large Molecule Bioanalytical Testing Services Market by Test Type: Movement Analysis
6.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 - 2030 (USD Million) for the following:
6.4. ADME
6.5. PD
6.6. Bioavailability
6.7. Bioequivalence
6.8. Other Tests
Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Area Estimates & Trend Analysis
7.1. Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area: Segment Dashboard
7.2. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Area: Movement Analysis
7.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million) for the following:
7.4. Oncology
7.5. Infectious Diseases
7.6. Cardiology
7.7. Neurology
7.8. Others
Chapter 8. Large Molecule Bioanalytical Testing Services Market by End Use Estimates & Trend Analysis
8.1. Large Molecule Bioanalytical Testing Services Market, By End Use: Segment Dashboard
8.2. Global Large Molecule Bioanalytical Testing Services Market by End Use: Movement Analysis
8.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million) for the following
8.4. SMEs
8.5. Large Firms
Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis
9.1. Regional market share analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. North America
9.4. Europe
9.5. Asia Pacific
9.6. Latin America
9.7. MEA
Chapter 10. Competitive Landscape
10.1. Market Categorization
10.2. Market Leaders
10.3. Emerging Players
10.4. Market Position Analysis, 2024
10.5. Company Profiles
10.5.1. Laboratory Corporation of America Holdings
10.5.2. IQVIA
10.5.3. Syneous Health
10.5.4. SGS, SA
10.5.5. WuXi AppTec
10.5.6. Intertek plc
10.5.7. Pace Analytical Services LLC
10.5.8. ICON PLC
10.5.9. Charles River Laboratories
10.5.10. Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/espxl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
